Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Neuromyelitis optica spectrum disorders: beyond longitudinally extensive transverse myelitis.
Recovery From Central Nervous System Acute Demyelination in Children.
Transfer of myelin-reactive th17 cells impairs endogenous remyelination in the central nervous system of cuprizone-fed mice.
Investigation of Fatigability during Repetitive Robot-Mediated Arm Training in People with Multiple Sclerosis.
Neuromyelitis optica spectrum disorders may be misdiagnosed as Wernicke's encephalopathy.
Brainstem and limbic encephalitis with paraneoplastic neuromyelitis optica.
Drosophila Neuronal Injury Follows a Temporal Sequence of Cellular Events Leading to Degeneration at the Neuromuscular Junction.
Vitamin A: yet another player in multiple sclerosis pathogenesis?
Consensus Statement on medication use in multiple sclerosis by the Spanish Society of Neurology's study group for demyelinating diseases.
Acute mountain sickness in athletes with neurological impairments.
A confusing case of multiple sclerosis and central nervous system graft versus host disease.
Robust Non-Local Multi-Atlas Segmentation of the Optic Nerve.
Antibodies against interferon-beta in neuromyelitis optica patients.
Elevated serum levels of lysophosphatidic acid in patients with multiple sclerosis.
Multicystic demyelinating myelopathy: Widening spectrum of pediatric aquaporin-4 autoimmunity.
Teaching NeuroImages: Neuromyelitis optica misdiagnosed as spinal cord tumor.
Current standards of treatment in ms and the role of oral agents.
[There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis.]
Methionyl-tRNA Formyltransferase (MTFMT) Deficiency Mimicking Acquired Demyelinating Disease.
Whole-body in vivo monitoring of inflammatory diseases exploiting human interleukin 6-luciferase transgenic mice.
Long-term results from a phase 2 extension study of fingolimod at high and approved dose in relapsing multiple sclerosis.
The Role of 3-O-Sulfogalactosylceramide, Sulfatide, in the Lateral Organization of Myelin Membrane.
Chaperone activity of small heat shock proteins underlies therapeutic efficacy in experimental autoimmune encephalomyelitis.
Sphingosine-1-phosphate receptor inhibition prevents denervation-induced dendritic atrophy.
[Alemtuzumab for relapsing-remitting multiple sclerosis : Results of two randomized controlled phase III studies.]
Pages
« first
‹ previous
…
483
484
485
486
487
488
489
490
491
…
next ›
last »